HK1176938A1 - 4 - azido - nucleosides as anti - hcv compunds hcv 4-- - Google Patents
4 - azido - nucleosides as anti - hcv compunds hcv 4--Info
- Publication number
- HK1176938A1 HK1176938A1 HK13104289.7A HK13104289A HK1176938A1 HK 1176938 A1 HK1176938 A1 HK 1176938A1 HK 13104289 A HK13104289 A HK 13104289A HK 1176938 A1 HK1176938 A1 HK 1176938A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hcv
- compunds
- nucleosides
- azido
- hcv compunds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29922910P | 2010-01-28 | 2010-01-28 | |
| PCT/EP2011/050971 WO2011092158A1 (en) | 2010-01-28 | 2011-01-25 | 4 ' - azido - nucleosides as anti - hcv compunds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1176938A1 true HK1176938A1 (en) | 2013-08-09 |
Family
ID=43587111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13104289.7A HK1176938A1 (en) | 2010-01-28 | 2013-04-09 | 4 - azido - nucleosides as anti - hcv compunds hcv 4-- |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8236779B2 (ja) |
| EP (1) | EP2528930B1 (ja) |
| JP (1) | JP5675849B2 (ja) |
| KR (1) | KR101384389B1 (ja) |
| CN (1) | CN102725303B (ja) |
| BR (1) | BR112012015951A2 (ja) |
| CA (1) | CA2784330C (ja) |
| DK (1) | DK2528930T3 (ja) |
| ES (1) | ES2437933T3 (ja) |
| HK (1) | HK1176938A1 (ja) |
| MX (1) | MX337050B (ja) |
| PL (1) | PL2528930T3 (ja) |
| PT (1) | PT2528930E (ja) |
| RU (1) | RU2556991C2 (ja) |
| TW (1) | TW201141488A (ja) |
| WO (1) | WO2011092158A1 (ja) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8877731B2 (en) * | 2010-09-22 | 2014-11-04 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| US9243025B2 (en) | 2011-03-31 | 2016-01-26 | Idenix Pharmaceuticals, Llc | Compounds and pharmaceutical compositions for the treatment of viral infections |
| EP2755983B1 (en) | 2011-09-12 | 2017-03-15 | Idenix Pharmaceuticals LLC. | Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections |
| WO2013056046A1 (en) | 2011-10-14 | 2013-04-18 | Idenix Pharmaceuticals, Inc. | Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| WO2013177188A1 (en) | 2012-05-22 | 2013-11-28 | Idenix Pharmaceuticals, Inc. | 3',5'-cyclic phosphoramidate prodrugs for hcv infection |
| AP3913A (en) | 2012-05-22 | 2016-11-26 | Idenix Pharamaceuticals Inc | D-amino acid compounds for liver disease |
| US9296778B2 (en) | 2012-05-22 | 2016-03-29 | Idenix Pharmaceuticals, Inc. | 3′,5′-cyclic phosphate prodrugs for HCV infection |
| EP2861611B1 (en) | 2012-05-25 | 2016-07-13 | Janssen Sciences Ireland UC | Uracyl spirooxetane nucleosides |
| WO2014052638A1 (en) | 2012-09-27 | 2014-04-03 | Idenix Pharmaceuticals, Inc. | Esters and malonates of sate prodrugs |
| EA030189B8 (ru) | 2012-10-08 | 2018-10-31 | Иденикс Фармасьютикалз Ллс | Аналоги 2'-хлоронуклеозидов для инфекции вгс |
| US10723754B2 (en) | 2012-10-22 | 2020-07-28 | Idenix Pharmaceuticals Llc | 2′,4′-bridged nucleosides for HCV infection |
| WO2014099941A1 (en) | 2012-12-19 | 2014-06-26 | Idenix Pharmaceuticals, Inc. | 4'-fluoro nucleosides for the treatment of hcv |
| US9339541B2 (en) | 2013-03-04 | 2016-05-17 | Merck Sharp & Dohme Corp. | Thiophosphate nucleosides for the treatment of HCV |
| US9309275B2 (en) | 2013-03-04 | 2016-04-12 | Idenix Pharmaceuticals Llc | 3′-deoxy nucleosides for the treatment of HCV |
| WO2014160484A1 (en) | 2013-03-13 | 2014-10-02 | Idenix Pharmaceuticals, Inc. | Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv |
| US9187515B2 (en) | 2013-04-01 | 2015-11-17 | Idenix Pharmaceuticals Llc | 2′,4′-fluoro nucleosides for the treatment of HCV |
| WO2014197578A1 (en) | 2013-06-05 | 2014-12-11 | Idenix Pharmaceuticals, Inc. | 1',4'-thio nucleosides for the treatment of hcv |
| EP3027636B1 (en) | 2013-08-01 | 2022-01-05 | Idenix Pharmaceuticals LLC | D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease |
| WO2015161137A1 (en) | 2014-04-16 | 2015-10-22 | Idenix Pharmaceuticals, Inc. | 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv |
| SI3154526T1 (sl) * | 2014-06-13 | 2019-08-30 | Ratiopharm Gmbh | Trdne oblike sofosbuvira |
| EP3236972B1 (en) | 2014-12-26 | 2021-07-28 | Emory University | Anti-viral n4-hydroxycytidine derivatives |
| WO2016204531A1 (ko) * | 2015-06-16 | 2016-12-22 | 엘지전자(주) | 블록 경계에 따라 적응적으로 필터링을 수행하는 방법 및 장치 |
| CA3082191C (en) | 2017-12-07 | 2021-09-21 | Emory University | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| CN113880903A (zh) * | 2021-09-23 | 2022-01-04 | 厦门蔚嘉制药有限公司 | 莫那比拉韦的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001079246A2 (en) * | 2000-04-13 | 2001-10-25 | Pharmasset, Ltd. | 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| ATE491459T1 (de) * | 2000-10-18 | 2011-01-15 | Pharmasset Inc | Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation |
| AU2002243791B2 (en) * | 2001-01-22 | 2006-06-29 | Isis Pharmaceuticals, Inc. | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
| MXPA04010983A (es) * | 2002-05-06 | 2005-02-14 | Genelabs Tech Inc | Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c. |
| TWI332507B (en) * | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
| CN100351264C (zh) * | 2002-11-19 | 2007-11-28 | 霍夫曼-拉罗奇有限公司 | 抗病毒核苷衍生物 |
| BRPI0619890A2 (pt) * | 2005-12-14 | 2011-10-25 | Hoffmann La Roche | composição farmacêutica e processo para preparação de uma suspensão sólida |
| US20090318380A1 (en) * | 2007-11-20 | 2009-12-24 | Pharmasset, Inc. | 2',4'-substituted nucleosides as antiviral agents |
| AR069740A1 (es) * | 2007-11-29 | 2010-02-17 | Metabasis Therapeutics Inc | Compuestos nucleosidos antivirales |
-
2011
- 2011-01-25 RU RU2012136379/04A patent/RU2556991C2/ru not_active IP Right Cessation
- 2011-01-25 TW TW100102705A patent/TW201141488A/zh unknown
- 2011-01-25 BR BR112012015951A patent/BR112012015951A2/pt active Search and Examination
- 2011-01-25 PL PL11701107T patent/PL2528930T3/pl unknown
- 2011-01-25 EP EP11701107.2A patent/EP2528930B1/en not_active Not-in-force
- 2011-01-25 CA CA2784330A patent/CA2784330C/en not_active Expired - Fee Related
- 2011-01-25 MX MX2012008443A patent/MX337050B/es active IP Right Grant
- 2011-01-25 ES ES11701107.2T patent/ES2437933T3/es active Active
- 2011-01-25 PT PT117011072T patent/PT2528930E/pt unknown
- 2011-01-25 JP JP2012550415A patent/JP5675849B2/ja not_active Expired - Fee Related
- 2011-01-25 DK DK11701107.2T patent/DK2528930T3/da active
- 2011-01-25 KR KR1020127022217A patent/KR101384389B1/ko not_active IP Right Cessation
- 2011-01-25 WO PCT/EP2011/050971 patent/WO2011092158A1/en active Application Filing
- 2011-01-25 CN CN201180007367.0A patent/CN102725303B/zh not_active Expired - Fee Related
- 2011-01-26 US US13/014,022 patent/US8236779B2/en not_active Expired - Fee Related
-
2013
- 2013-04-09 HK HK13104289.7A patent/HK1176938A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5675849B2 (ja) | 2015-02-25 |
| TW201141488A (en) | 2011-12-01 |
| MX337050B (es) | 2016-02-10 |
| BR112012015951A2 (pt) | 2018-10-16 |
| DK2528930T3 (da) | 2013-11-11 |
| CA2784330C (en) | 2018-02-13 |
| CN102725303A (zh) | 2012-10-10 |
| PT2528930E (pt) | 2013-11-26 |
| RU2012136379A (ru) | 2014-03-10 |
| RU2556991C2 (ru) | 2015-07-20 |
| CA2784330A1 (en) | 2011-08-04 |
| KR101384389B1 (ko) | 2014-04-10 |
| JP2013518076A (ja) | 2013-05-20 |
| MX2012008443A (es) | 2012-08-15 |
| CN102725303B (zh) | 2015-05-27 |
| EP2528930B1 (en) | 2013-10-30 |
| WO2011092158A1 (en) | 2011-08-04 |
| US8236779B2 (en) | 2012-08-07 |
| EP2528930A1 (en) | 2012-12-05 |
| KR20120110177A (ko) | 2012-10-09 |
| ES2437933T3 (es) | 2014-01-15 |
| US20110150829A1 (en) | 2011-06-23 |
| PL2528930T3 (pl) | 2014-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1176938A1 (en) | 4 - azido - nucleosides as anti - hcv compunds hcv 4-- | |
| HUS1500019I1 (hu) | Hepatitisz C vírus inhibitorok | |
| EP2575866A4 (en) | HCV NS5A INHIBITORS | |
| EP2575475A4 (en) | HCV NS5A INHIBITORS | |
| PL2528922T3 (pl) | Związki poliheterocykliczne jako inhibitory hcv | |
| IL219696A0 (en) | Hcv combination therapy | |
| ZA201109150B (en) | Biochar complex | |
| IL219516A0 (en) | Hepatitis c virus inhibitors | |
| HK1163067A1 (en) | Hepatitis c virus inhibitors | |
| HK1150423A1 (en) | Utility glove | |
| IL219517A0 (en) | Hepatitis c virus inhibitors | |
| EP2398474A4 (en) | HCV NS5A SHEMMER | |
| IL215055A0 (en) | Hepatitis c virus inhibitors | |
| IL214939A0 (en) | Hepatitis c virus inhibitors | |
| IL214775A0 (en) | Hepatitis c virus inhibitors | |
| EP2512480A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| EP2475254A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| EP2475256A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| IL224178A (en) | Heterogeneous history of cervix as hcv inhibitors | |
| EP2429568A4 (en) | MACROCYCLIC COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS | |
| AU328277S (en) | Glove | |
| EP2538427A4 (en) | TOUCH | |
| GB0912950D0 (en) | Virus | |
| GB2467310B (en) | Glove | |
| GB0901056D0 (en) | Virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190120 |